Dr. Goenka is board-certified in radiation oncology and physics and has extensive experience with proton radiotherapy, intensity modulated radiation therapy, stereotactic body radiation therapy and brachytherapy applications.

He received his medical degree at Johns Hopkins University and completed his post graduate training at Memorial Sloan-Kettering Cancer Center. He specializes in the treatment of cancers of all subsites, including brain, head and neck, lung, breast, esophageal, colorectal/anal, prostate, and gynecological malignancies.

Dr. Goenka is the recipient of several leadership awards, has published numerous articles and abstracts in national and international journals and has participated as a guest speaker internationally. He holds memberships at the American Medical Association, American Society

for Therapeutic Radiology and Oncology, and American Association of Physicians of Indian Origin among others and is actively involved in Community Outreach programs.

Louis Potters, MD, FACR, FASTRO FABS is chairperson of the Department of Radiation Medicine at Northwell Health and professor at the Zucker School of Medicine at Hofstra/Northwell. He is Deputy Physician in Chief and the Marilyn and Barry Rubenstein Chair in Cancer Research for the Northwell Health Cancer Institute. He holds an Affiliate Membership at the Cold Spring Harbor Laboratory Cancer Institute.

Dr. Potters is a practicing radiation oncologist and an internationally recognized expert in the management and treatment of prostate cancer. He has authored more than 150 publications, book chapters and editorials. Board-certified in internal medicine and radiation oncology, Dr. Potters previously served as Medical Director of the New York Prostate Institute and as associate member in radiation oncology at Memorial Sloan Kettering Cancer Center. He received his medical degree from the Rutgers Medical School, and his undergraduate degree from Emory University.

Dr. Potters is currently President for the Society of Chairs in Academic Radiation Oncology Programs (SCAROP) has served as a board member and other leadership roles for the American Society of Radiation Oncology and other medical societies. He has authored several key national cancer treatment guidelines for radiation oncology. Dr. Potters has been a consultant for the US Nuclear Regulatory Commission, the National Quality Forum and the Agency for Healthcare Research and Quality. He has served as an executive committee member for the American College of Surgeons Commission on Cancer and has participated on several US Department of Health and Human Services committees and panels. He is currently on the Board for the Long Island Chapter of the American Cancer Society and is the founding Chair of the Northwell Health Physician Partners Board of Governors, the eighth largest medical group in the US.

Dr. Potters oversees one of the largest radiation oncology departments with a faculty and staff devoted to excellent patient care, research and the education of tomorrow’s oncologists. The department is recognized as a pioneer for high quality and safe cancer care through its Smarter Radiation Oncology initiative.

Dr. Andrews is a board-certified Radiation Oncologist.  Dr. Andrews is the Director of Radiation Oncology at Phelps Hospital, Northwell Health. Dr. Andrews is an Associate Clinical Professor of Radiation Oncology, at the Zucker Hofstra School of Medicine. She received her undergraduate degree in Molecular Biology at Princeton University.  Dr. Andrews attended Temple University School of Medicine and completed her residency in radiation oncology at Emory University.  She also completed a GU fellowship with Dr. Mack Roach at University of California in San Francisco.  Dr. Andrews’ training at Emory included spending a significant amount of time at the public hospital Grady Memorial which allowed her to witness firsthand the disparities in oncology.  This experience cemented Dr. Andrews’ commitment to working to eradicate disparities in the field of oncology through patient and physician education.

Dr. Barbee is the Director of Radiation Oncology Physics in the NYU Langone Health System where he oversees all clinical physics operations.  Dr. Barbee is currently a Clinical Associate Professor at NYU Langone Health, where he has been for 5.5 years, having previously worked as a clinical medical physicist in the greater New York City area for the past 11 years.

His primary work interests involve informatics of radiation oncology data systems, automation of machine QA, and development of applications and data systems for management of clinical operations and workflow.  Dr. Barbee received his PhD from the University of Wisconsin – Madison in Medical Physics in 2009 and ABR certification in therapeutic medical physics in 2013.

Board certifications
Therapeutic Radiology – American Board of Radiology / Therapeutic Radiology

Academic titles
Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Education
Albany Medical College

Residencies
Thomas Jefferson University Hospital & Med College

Internships
Medical College of Pennsylvania Hospital

Affiliations
Glen Cove Hospital
Lenox Hill Hospital
Long Island Jewish Medical Center
North Shore University Hospital
Northern Westchester Hospital
Phelps Memorial Hospital Center
Southside Hospital
Northwell Health Cancer Institute

Serving as chief physicist of Department of Radiation Medicine at Northwell, Yijian Cao, Ph.D, oversees and coordinates clinical medical physics operations at all 8 department sites. He is also to develop and grow research and education programs in radiation oncology physics and clinical dosimetry. His research focuses are the optimizations and automations of treatment planning, AI/ML for clinical QA procedures, and workflow management and integration for safety and efficiency. He teaches in Hofstra medical physics graduate program.

Board Certifications
Therapeutic Medical Physics – American Board of Medical Physics

Administrative Titles
Director of Medical Physics – Department of Radiation Medicine, Northwell

Academic Titles
Assistant professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell
Adjunct associate professor, Department of Physics, Hofstra University

Education
B.S. – Physics, Nanking University
Ph.D – Condensed Matter Physics, University of Missouri-Columbia

Attending Physicist, Chief of Radiotherapy Physics Service; Vice Chair Radiotherapy Physics (Acting)

Education
PhD, MSc, in aerospace engineering, University of California, San Diego; BSc in aeronautical engineering, Universidad Politecnica de Madrid, Spain

I was born and raised in Spain and have a background in aeronautical engineering. After my undergraduate studies, I came to the US to pursue graduate studies. I completed my PhD in mechanical and aerospace engineering at the University of California, San Diego, followed by a postdoctoral fellowship in radiology and radiation oncology.

I joined the Medical Physics faculty at UC San Diego in 2009 where I was the Breast and Gynecological Cancers Physics Service Chief and the Assistant Vice Chair for Diversity. I recently moved to MSK as the Chief of the Radiotherapy Physics Service in the Department of Medical Physics.

I have a strong clinical and research interest in image-guided radiation therapy, motion management, patient safety, and automation.

Dr. Jenghwa Chang is a medical physicist certified by ABR and ABMP. His major clinical responsibility is Gamma Knife stereotactic radiosurgery/radiotherapy and he is currently the lead physicist for the Gamma Knife SRS/SBRT program at Northwell Health. Dr. Chang is the Director of the Medical Physics Residency Program at Northwell Health and is teaching for the Medical Physics Graduate Program of Hofstra University.

Dr. Chang received the B.S. degree in control engineering and the M.S. degree in communication engineering, both from the National Chiao-Tung University, Hsinchu, Taiwan, and earned his Ph.D. degree in electrical engineering from the Polytechnic Institute of New York University, Brooklyn. Prior to his current position, Dr. Chang held faculty appointments at New York Presbyterian Hospital-Weill Cornell Medical College (2010-2016), NYU Langone Medical Center (2008-2009), and Memorial Sloan-Kettering Cancer Center (1997-2008). Dr. Chang is a member of IEEE, AAPM and ASTRO. He is actively involved in professional activities and has served multiple committees and officers for AAPM and RAMPS. He has also offered several SAM educational/professional lectures to colleagues at various national/international meetings, and is a site surveyor for the ACR ROPA program.

Dr. Chang’s research interest involves applying engineering and physics principles to medicine, particularly, in the fields of radiology and radiation oncology. He has published over 60 peer-reviewed journal articles in the fields of electrical engineering, medical physics, radiation oncology and biomedical engineering. Dr. Chang was a pioneer in optical diffusion tomography for early detection of breast cancers. He has also implemented the cone-beam computed tomography on a medical linear accelerator to improve the treatment setup accuracy and critical organ avoidance for radiation oncology patients.  Currently, he is focusing on the research of quality improvement, automation, deep-learning network and small field dosimetry. Dr. Chang is a reviewer for multiple international peer-reviewed journals, including Medical Physics, International Journal of Radiation Oncology Biology Physic, Journal of Applied Clinical Medical Physics.

Anne W. Greener, Ph.D. is Chief Therapeutic Medical Physicist at the New Jersey Veterans Hospital in East Orange, New Jersey.   She is a New Jersey native and prior to joining the New Jersey VA in 2009, spent over 25 years working in many different roles at several New Jersey community hospitals and free-standing centers.  Dr. Greener holds certifications by the American Board of Radiology in Medical Nuclear Physics (1988) and in Therapeutic Radiological Physics (1993). She is a Fellow in the American Association of Physicists in Medicine (AAPM) and American College of Radiology (ACR).  Throughout her career, Dr. Greener taught Radiologic Technologists, Nuclear Medicine Technologists, Medical Dosimetrists, Radiology and Radiation Oncology Residents.  She commissioned advanced practice technologies at several community facilities and the VA, including IMRT/VMAT, SRS, SBRT, LDR for prostate and HDR.  At a national level, Dr. Greener has contributed to the education and professionalism of Medical Dosimetrists, presented on quality and safety in Radiation Oncology and participates in VA and professional working groups.  As a member of AAPM Working Group for Prevention of Errors, she helped author Strategies for Effective Physics Plan and Chart Review in Radiation Therapy: Report of AAPM Task Group 275, (2020).

Joseph M. Herman, MD is currently Director of Clinical Research for the Northwell Health Cancer Institute and Vice-Chair of Clinical Informatics in the Department of Radiation Oncology.

Previously, he was Professor and Ad Interim Division Head in Radiation Oncology at The University of Texas MD Anderson Cancer Center. Prior to this he was an Associate Professor at Johns Hopkins University Department of Radiation Oncology, where he was director of the gastrointestinal division. He has served as Principal Investigator for several institutional gastrointestinal protocols and is a Co-Investigator (radiation oncology lead) for the Alliance 021101 borderline re-sectable cancer trial, which is evaluating the role of stereotactic body radiation therapy (SBRT) for such cases. His major areas of clinical and basic research involve identification of novel biomarkers and integration of SBRT and hypofractionated radiation with immunotherapy and targeted therapies.

Dr. Theodore Hong is the Director of Gastrointestinal Radiation Oncology at Massachusetts General Hospital and Professor of Radiation Oncology at Harvard Medical School.   He also is the Co-Leader of the Dana-Farber/Harvard Cancer Center Gastrointestinal Malignancies Research Program.

He serves as the Chair of the Non-Colorectal Gastrointestinal Committee for NRG Oncology. His research interests include proton therapy, targeted therapies, immunotherapy, and biomarker development for GI cancers.

Education
MA, Chemical Biology, Harvard University; MD, University of California, San Francisco School of Medicine; Certificate Program in Clinical Effectiveness, Harvard University T.H. Chan School of Public Health

Residencies
Radiation Oncology – Memorial Sloan Kettering Cancer Center

Fellowships
Lymphoma Radiotherapy – Memorial Sloan Kettering Cancer Center

I am a radiation oncologist who cares for people with blood cancers and tumors affecting the brain and central nervous system. I see patients in Manhattan and our Regional Care Network on Long Island. As a graduate of Commack High School, I feel fortunate to be able to offer compassionate, state-of-the-art care to the communities where I grew up.

I received my bachelor’s and master’s degrees in chemistry from Harvard University. I earned my medical degree at the University of California, San Francisco, dedicating an additional year to research focused on the aggressive brain cancer glioblastoma. My specialty training was at Memorial Sloan Kettering, where I also completed a clinical research fellowship in lymphoma radiation oncology. As a resident, I obtained specialized training in clinical research at the Harvard School of Public Health.

I was drawn to oncology, and radiation oncology specifically, because of the strong bonds formed between patient and physician. A cancer diagnosis and the prospect of radiation therapy can be intimidating, overwhelming, and frightening. I believe that critical first steps are to communicate clearly to ease fears, provide full explanations of options, and answer questions. My team and I strive to be our patients’ unwavering advocates and aim to offer strong emotional and physical support at every step of the process.

When treating blood cancers like lymphoma, multiple myeloma, and leukemia, as well as certain brain tumors, I implement advanced radiation techniques including intensity modulated radiation therapy and image-guided radiation therapy to safely and effectively treat these cancers. For brain metastases and benign tumors, I often rely on highly focal modalities like MSK Precise™ stereotactic radiosurgery.

Read more
I am a strong believer in a multidisciplinary approach to patient care and am a member of several clinical teams, including the Lymphoma Disease Management Team and MSK’s Brain Metastasis Center. I work collaboratively with my patients’ other providers, including medical oncologists, surgeons, radiologists, and pathologists to develop a highly personalized care plan guided by the latest clinical evidence. I feel very strongly that patients and their families should be participants in this process to tailor the treatment plan according to specific goals and concerns.

In addition to caring for patients, I participate in several research programs which fall under two broad themes: improvement of outcomes and reduction of side effects for blood and brain cancer treatments. I am particularly interested in designing clinical trials which combine radiotherapy with other novel cancer therapies. For example, I am currently studying potential ways to combine radiation with highly innovative CAR T cell therapies to enhance treatment responses in aggressive lymphomas like diffuse large B-cell lymphoma. To minimize side effects and increase patient convenience, I am studying how we can safely reduce the number of radiation treatments necessary for less-aggressive lymphomas like cutaneous T-cell lymphomas. I am also working closely with colleagues in neurosurgery and neuro-oncology to evaluate new technologies for brain brachytherapy, a specialized way to deliver radiation in the operating room very focally to the edges of a surgical cavity while sparing much of the surrounding healthy brain tissue.

I feel privileged to practice at MSK given our ability to offer world-class treatment approaches including promising clinical trials which might not be available elsewhere. When I am not working, I enjoy spending time with my family, brewing craft coffee, running in Central Park, and hiking in upstate New York.

My team and I strive to be our patients’ unwavering advocates and aim to offer strong emotional and physical support at every step of the process.

-Dr. Imber

Awards and Honors

• Chief Resident, Radiation Oncology, Memorial Sloan Kettering Cancer Center (2020)
• Abstract Award, American Society of Hematology (2019)
• Resident Research Grant, American College of Radiation Oncology (2018)
• Dr. Mortimer J. Lacher, MD Fellowship award in Lymphoma, Memorial Sloan Kettering Cancer Center (2018)
• Resident Essay Award, American College of Radiation Oncology (2017)
• Alpha Omega Alpha Medical Honor Society, UCSF (2014)

Assistant Attending Physicist

Education
PhD, Rutgers University; MASc, University of British Columbia; BASc (Hons.), University of British Columbia

I am a board-certified assistant attending medical physicist in the Dosimetry Core of the Clinical Physics Service. I have contributed to various roles from commissioning treatment machines and treatment planning systems (TPS) to clinical research and development. I am currently leading the effort in commissioning and establishing the quality assurance (QA) program of MR LINAC and the in-house solution for independent calculation. I am also involved in the development of a new machine QA program that will provide a scalable standardized workflow and a more quantitative approach for network-wide monitoring and analysis.

As the leader of the TPS, I use the latest technology to improve the accuracy and precision of radiation treatment delivery. I am also involved in training medical physics residents in the area of QA and commissioning.

Director of Medical Physics

Dr. Haibo Lin is a proton physicist specializing in machine and planning support, dosimetry and quality assurance who serves as the center’s Director of Medical Physics. He completed his medical physics training in 2011 at the University of Pennsylvania and served as the chief resident. Upon graduation from residency, he became an adjunct assistant professor, medical physicist and lead proton physicist at the Roberts Proton Therapy Center at Penn Medicine.

Dr. Mutter is an Associate Professor in the Department of Radiation Oncology at the Mayo Clinic where he leads the enterprise-wide radiation oncology breast cancer disease site group.  Dr. Mutter specializes in the development of novel fractionation schedules and treatment delivery to reduce side effects of radiotherapy. For example, Dr. Mutter studies particle therapy from multiple points of view, including identifying patients most likely to benefit, optimizing combined modality therapy, and integrating proton therapy with breast reconstruction.

In addition, Dr. Mutter’s laboratory investigates ways to enhance the efficacy of radiotherapy in patients with resistant breast cancer through an improved understanding of breast cancer biology and DNA repair.

Specialties

Radiation Oncology

Expertise

Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer

Biography

Dr. Himanshu Nagar is a board certified radiation oncologist who specializes in caring for patients with genitourinary malignancies.

Dr. Nagar received his undergraduate degree from Johns Hopkins University and his medical degree from the University of Texas Health Science Center at Houston. He completed his residency at NewYork-Presbyterian Hospital/Weill Cornell Medicine. Dr. Nagar is the recipient of numerous honors, including the Physician of the Year Award from NewYork-Presbyterian Hospital along with multiple research grants, scholarships, and awards.

Dr. Nagar uses the most advanced technology available for patients with prostate cancer including real-time MRI guidance and rectal spacer to deliver safer radiotherapy in as short as 5 visits.

Dr. Nagar is actively involved in both translational and clinical research at Weill Cornell Medicine including several clinical trials. Dr. Nagar’s research is aimed at better defining and tailoring the role of radiotherapy for various genitourinary malignancies.

Board certifications
Radiation Oncology – American Board of Radiology / Radiation Oncology

Administrative titles
Chairman of Radiation Medicine, Northern Westchester Hospital

Academic titles
Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Education
Bangalore Medical College

Residencies
Loyola University Medical Center

Internships
St Agnes Medical Center

Affiliations
Huntington Hospital
Lenox Hill Hospital
Long Island Jewish Medical Center
North Shore University Hospital
Northern Westchester Hospital
Phelps Memorial Hospital Center
Southside Hospital
Staten Island University Hospital
Northwell Health Cancer Institute

Dr. Arjun Sahgal is an international clinical and research leader in the field of high precision stereotactic radiation to the brain and spine for both metastases and primary tumors. After training at the University of Toronto in radiation oncology, he completed a radiosurgery fellowship at the University of California San Francisco. He has published, as lead or as a contributor, over 400 peer reviewed papers including in high impact journals like the Journal of Clinical Oncology, Lancet Oncology, and New England Journal of Medicine. He leads the Sunnybrook Odette CNS Neuro-Oncology program that has been awarded a total of $42.5 M in funding since his leadership.

Currently, he serves as Deputy Chief of the Department of Radiation Oncology at the University of Toronto affiliated Sunnybrook Odette Cancer Centre. In addition, he is the director of the Sunnybrook Cancer Ablation Therapy (CAT) program which involved the installation of a MR Brachytherapy suite, MR Linac and Gamma Knife Icon technology. His next phase of research is in the development of MR in radiation therapy, and the application of MR Guided Focused Ultrasound Technology with radiation.

Board certifications
Radiation Oncology – American Board of Radiology / Radiation Oncology

Academic titles
Assistant Professor, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell

Chief resident
Montefiore Medical Center – Moses Division

Education
Temple University School of Medicine

Residencies
Montefiore Medical Center – Moses Division

Internships
Drexel University College of Medicine

Fellowships
Univ of Texas MD Anderson Cancer Center

Affiliations
Glen Cove Hospital
Lenox Hill Hospital
Long Island Jewish Medical Center
North Shore University Hospital
Northern Westchester Hospital
Phelps Memorial Hospital Center
Southside Hospital
Northwell Health Cancer Institute

Dan Spratt, MD, is a leader in Prostate and Spine malignancies. In addition to his medical training at Vanderbilt University where he obtained his medical degree, he completed his Radiation Oncology Residency at Memorial Sloan Kettering Cancer Center. In the Department of Radiation Oncology, Dr. Spratt is the Chief of the Genitourinary Radiotherapy Program, Associate Chair of Clinical Research, and the Laurie Snow Endowed Research Professor. In the Rogel Cancer Center he is the co-Chair of the Genitourinary Clinical Research Team and co-Director of the Spine Oncology Program. He holds leadership positons in the NIH U-10 LAPS cooperative group trial efforts and Prostate Cancer SPORE, and is the co-Chair for Prostate Cancer Foundations Health Disparities Working Group. He is the head of the Intact Prostate Cancer Subcommittee within the NRG Genitourinary Core Committee for national clinical trials, and a committee member for the NCCN Prostate Cancer national guidelines.

Dr. Spratt has received funding from the National Institutes of Health, Department of Defense, and multiple other funding bodies and foundations for his research. He has published over 250 papers primarily on the topics of prostate cancer and prognostic and predictive biomarkers. He has developed widely used clinical and clinicogenomic models for prostate cancer, multiple of which are cited in the National Comprehensive Cancer Network (NCCN) guidelines. He is the PI of >10 prostate cancer clinical trials, including the multinational randomized phase II BALANCE trial (NRG GU006), North-American PI of the STAMPEDE Arm M phase III trial, national PI of the ASCLEPIUS multicenter phase I/II trial, multi-center PI for G-MAJOR randomized phase III trial, and multiple institutional trials. His laboratory focuses on the interaction of androgen signaling and DNA repair in prostate cancer and methods to overcome radiation resistance.

It is a privilege to take care of people with cancer. I am a radiation oncologist at Lenox Hill Hospital where I work alongside the very best surgeons, oncologists, and clinical staff to give our patients the best possible results. I am also Associate Professor of Radiation Medicine at Zucker School of Medicine at Hofstra/Northwell, where I mentor and teach medical students and residents.

In addition to treating cancer, I perform research on how to use technology to improve patient care. I publish my results in scientific journals, and have also presented my research at national and international conferences.

I joined Northwell Health in 2014 after training at Memorial Sloan Kettering Cancer Center, where I was Chief Resident. At Lenox Hill, I work with a team of experts to give each patient the best personalized treatment for their cancer. My clinical practice includes cancers of the head-and-neck, gastrointestinal system, brain, lung, and breast. My research focuses on head-and-neck cancers and ways to improve the quality and delivery of medical care.